investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Predictive biomarkers of response to DNA repair targeting agents in sporadic prostate cancer
Joaquin Mateo Valderrama
0 Collaborator(s)
Funding source
Medical Research Council (MRC)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Joaquin Mateo Valderrama
Institute of Cancer Research
London, United Kingdom
Related projects
Sophie Papa
Clinical Translation of Gene Modified T-cell Therapy for Solid Tumours
Prostate
Deborah Enting
Influence of stage and therapy on the NKG2D axis in prostate cancer
Prostate
Georgios Giamas
Compound Screening for the Identification of LMTK3 Kinase-Inhibitors
Prostate
Alastair Davies
A Cancer Stem Cell-Directed Therapy for Enzalutamide-Resistant Prostate Cancer
Prostate
Surgery / Surgical oncology
Investigator from Kinasera Ou
Prostate cancer diagnostic assay based on protein kinase activity profiling in exosomes
Prostate
Demetrius Albanes
Endogenous Hormones and Prostate Cancer Collaborative Group
Prostate
Donna L. Berry
Personal Patient Profile-Prostate: Testing and Implementation in Health Networks
Prostate
Radiation Oncology
Surgery / Surgical oncology
Harry Ostrer
Genomics and Predictive Modeling of Prostate Cancer Heath Disparity
Prostate
Stephen Choi
Targeting monocarboxylate transporter 4 (MCT4) for treatment of castration resistant prostate cancer (CRPC)
Prostate